Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma.

Hoell, PA; Elsayad, K; Berssenbruegge, H; Hering, D; Kittel, C; Kleinheinz, J; Bleckmann, A; Evers, G; Wardelmann, E; Rudack, C; Eich, HT (2023)

In: Anticancer Research, 43(3).

Forschungsartikel (Zeitschrift)

Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome

Elsayad K, Weishaupt C, Moustakis C, Danzer MF, Müller EC, Rolf D, Stranzenbach R, Livingstone E, Booken N, Stadler R, Eich HT (2023)

In: International Journal of Radiation Oncology - Biology - Physics, 117(1).

Forschungsartikel (Zeitschrift)

Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer

Troschel FM, Minte A, Ismail YM, Kamal A, Abdullah MS, Ahmed SH, Deffner M, Kemper B, Kiesel L, Eich HT, Ibrahim SA, Götte M, Greve B. (2020)

In: International Journal of Molecular Sciences, 21(6).

Forschungsartikel (Zeitschrift)

Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer

Oertel M, Scobioala S, Kroeger K, Baehr A, Stegger L, Haverkamp U, Schäfers M, Eich H-T (2018)

In: Radiation Oncology, 13(185).

Forschungsartikel (Zeitschrift)

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): An open-label, international, randomised phase 3 study by the German Hodgkin Study Group

Borchmann P., Haverkamp H., Lohri A., Mey U., Kreissl S., Greil R., Markova J., Feuring-Buske M., Meissner J., Dührsen U., Ostermann H., Keller U., Maschmeyer G., Kuhnert G., Dietlein M., Kobe C., Eich H., Baues C., Stein H., Fuchs M., Diehl V., Engert A. (2017)

In: Lancet Oncology, null(null).

Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma. Hoell, PA; Elsayad, K; Berssenbruegge, H; Hering, D; Kittel, C; Kleinheinz, J; Bleckmann, A; Evers, G; Wardelmann, E; Rudack, C; Eich, HT (2023) In: Anticancer Research, 43(3). Forschungsartikel (Zeitschrift)
Radiotherapeutic Treatment of indolent cutaneous B-cell Lymphomas - Results of a multicenter Registry Oertel, Michael; Storck, Michael; Goerlich, Dennis; Schnellhardt, Soeren; Bock, Felix; Linde, Philipp; Domschikowski, Justus; Peeken, Jan; Wittig, Andrea; Elsayad, Khaled; Siats, Jan; Rolf, Daniel; Combs, Stephanie E.; Baues, Christian; Dunst, Juergen; Hildebrandt, Guido; Fietkau, Rainer; Eich, Hans Theodor (2023) In: Strahlentherapie und Onkologie, 199. Forschungsartikel (Zeitschrift)
Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome Elsayad K, Weishaupt C, Moustakis C, Danzer MF, Müller EC, Rolf D, Stranzenbach R, Livingstone E, Booken N, Stadler R, Eich HT (2023) In: International Journal of Radiation Oncology - Biology - Physics, 117(1). Forschungsartikel (Zeitschrift)
Reduction of tumor volume during radiotherapy in patients with small-cell lung cancer and its prognostic significance. Kandler C; Elsayad K; Evers G; Siats J; Kittel C; Scobioala S; Bleckmann A; Eich HT (2023) In: Strahlentherapie und Onkologie, 199(11). Forschungsartikel (Zeitschrift)
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer Troschel FM, Minte A, Ismail YM, Kamal A, Abdullah MS, Ahmed SH, Deffner M, Kemper B, Kiesel L, Eich HT, Ibrahim SA, Götte M, Greve B. (2020) In: International Journal of Molecular Sciences, 21(6). Forschungsartikel (Zeitschrift)
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma Brand V, Greve B, Bölling T, Eich HT, Willich N, Harrach S, Hintelmann H, Lenz G, Mesters RM, Kessler T, Schliemann C, Berdel WE, Schwöppe C (2020) In: PloS one, 15(2). Forschungsartikel (Zeitschrift)
Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer Oertel M, Scobioala S, Kroeger K, Baehr A, Stegger L, Haverkamp U, Schäfers M, Eich H-T (2018) In: Radiation Oncology, 13(185). Forschungsartikel (Zeitschrift)
Quality control of involved field radiotherapy in the HD 13 and HD 14 trials: Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG) Kriz J., Baues C., Engenhart-Cabillic R., Haverkamp U., Herfart K., Lukas P., Plütschow A., Schmidberger H., Staar S., Fuchs M., Engert A., Eich H. (2017) In: Strahlentherapie und Onkologie, 193(2). Forschungsartikel (Zeitschrift)
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): An open-label, international, randomised phase 3 study by the German Hodgkin Study Group Borchmann P., Haverkamp H., Lohri A., Mey U., Kreissl S., Greil R., Markova J., Feuring-Buske M., Meissner J., Dührsen U., Ostermann H., Keller U., Maschmeyer G., Kuhnert G., Dietlein M., Kobe C., Eich H., Baues C., Stein H., Fuchs M., Diehl V., Engert A. (2017) In: Lancet Oncology, null(null). Forschungsartikel (Zeitschrift)
New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group Kriz J., Baues C., Engenhart-Cabillic R., Haverkamp U., Herfarth K., Lukas P., Schmidberger H., Marnitz-Schulze S., Fuchs M., Engert A., Eich H. (2017) In: Strahlentherapie und Onkologie, 193(2). Forschungsartikel (Zeitschrift)